How patients felt about CRC care — 5 survey insights

Metastatic colorectal care patients offered insights into clinician care in a survey presented at the 2019 World Congress on Gastrointestinal Cancer, July 3-6 in Barcelona, Spain, Medscape reports.

Advertisement

Researchers surveyed 883 patients across 15 European countries.

What you should know:

1. Eighty-seven percent of respondents said clinicians treated them within three months after diagnosis. Clinicians treated 22 percent in the first two weeks following diagnosis, 36 percent between two weeks and one month after diagnosis and 29 percent between one month and three months after diagnosis.

2. Seventy-six percent of patients said clinicians informed them of the adverse effects of treatments, while 12 percent of patients said they were not informed.

3. In Belgium, 84 percent of patients felt included in care plan decision-making, while in the U.K., 74 percent of patients felt their opinions weren’t considered.

4. The most common types of treatment were surgery (81 percent) and chemotherapy (90 percent).

More articles on surgery centers:
3 quotes on bundled payments in ASCs
5 new ASC developments expected to cost $10M+
Massachusetts provider group developing $10M joint venture ASC

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.